Pentwater Capital Management LP, 10% Owner at Tobira Therapeutics, Inc. (TBRA), bought 8,962 shares at $39.83 ($357K) on 2016-10-04, disclosed to the SEC on 2016-10-06.
Open-market purchase of $357k TBRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.83 | 4,481 | $178K | 50.0% |
| 2 | $39.83 | 4,481 | $178K | 50.0% |
| Total | $39.83 avg | 8,962 | $357K | 100% |
| Filing → |
| CAR | SELL | 2026-04-28 | $223.1M | — | Filing → |
| CAR | BUY | 2026-02-24 | $80.1M | — | Filing → |
| TBRA | BUY | 2016-11-02 | $628K | — | Filing → |